Former FDA Boss Proposes Cannabidiol Regulatory Plan

November 11, 2019 16:00:59

Players in the CBD industry may finally get a reprieve from the industry’s current state of unlawfulness. On Friday, former Food and Drug Administration (FDA) Scott Gottlieb described a potential regulatory system for the U.S. CBD industry. He laid out steps that the agency could take to give the sector some structure while the final rules are being developed.

The former Commissioner urged consumers to use CBD products with caution, arguing that most of the medical benefits that the products claim haven’t been proven anyway. He added that for the time being, the FDA could implement specific measures to ensure the products meet basic safety standards. “The CBD hype has outpaced science,” he said in a public statement, “and there are risks. But with use so widespread, the question is…


About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published:

Do you have a questions or are you interested in working with CNW? Ask Our Editor

Denver, Colorado
303.498.7722 Office

CBDWire is part of the InvestorBrandNetwork.